###begin article-title 0
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 61 78 61 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 207 216 207 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 61 77 <span type="species:ncbi:5855">Plasmodium vivax</span>
###xml 207 215 <span type="species:ncbi:5855">P. vivax</span>
###xml 224 232 <span type="species:ncbi:9606">patients</span>
Duffy blood group polymorphisms are important in areas where Plasmodium vivax predominates, because this molecule acts as a receptor for this protozoan. In the present study, Duffy blood group genotyping in P. vivax malaria patients from four different Brazilian endemic areas is reported, exploring significant associations between blood group variants and susceptibility or resistance to malaria.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 4 12 <span type="species:ncbi:5855">P. vivax</span>
###xml 175 183 <span type="species:ncbi:9606">patients</span>
The P. vivax identification was determined by non-genotypic and genotypic screening tests. The Duffy blood group was genotyped by PCR/RFLP in 330 blood donors and 312 malaria patients from four Brazilian Amazon areas. In order to assess the variables significance and to obtain independence among the proportions, the Fisher's exact test was used.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 38 46 38 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB </italic>
###xml 68 84 68 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB/FYB, FYA/FYA</italic>
###xml 86 97 86 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB-33 </italic>
###xml 101 111 101 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB/FYB-33</italic>
###xml 151 157 151 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FY</italic>
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X</italic></sup>
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB/FY</italic>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X</italic></sup>
###xml 169 175 169 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYX/FY</italic>
###xml 175 177 175 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 175 177 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X </italic></sup>
###xml 181 195 181 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33/FYB-33 </italic>
###xml 231 244 231 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33/FYB-33</italic>
###xml 352 354 352 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 354 355 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 354 355 354 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X</italic></sup>
###xml 355 363 355 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/FYB-33 </italic>
###xml 471 479 <span type="species:ncbi:9606">patients</span>
The data show a high frequency of the FYA/FYB genotype, followed by FYB/FYB, FYA/FYA, FYA/FYB-33 and FYB/FYB-33. Low frequencies were detected for the FYA/FYX, FYB/FYX, FYX/FYX and FYB-33/FYB-33 genotypes. Negative Duffy genotype (FYB-33/FYB-33) was found in both groups: individuals infected and non-infected (blood donors). No individual carried the FYX/FYB-33 genotype. Some of the Duffy genotypes frequencies showed significant differences between donors and malaria patients.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB </italic>
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33 </italic>
###xml 224 233 224 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 394 403 394 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 224 232 <span type="species:ncbi:5855">P. vivax</span>
###xml 394 402 <span type="species:ncbi:5855">P. vivax</span>
The obtained data suggest that individuals with the FYA/FYB genotype have higher susceptibility to malaria. The presence of the FYB-33 allele may be a selective advantage in the population, reducing the rate of infection by P. vivax in this region. Additional efforts may contribute to better elucidate the physiopathologic differences in this parasite/host relationship in regions endemic for P. vivax malaria, in particular the Brazilian Amazon region.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 285 287 285 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 294 303 294 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 0 16 <span type="species:ncbi:5855">Plasmodium vivax</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 183 189 <span type="species:ncbi:9606">humans</span>
###xml 294 302 <span type="species:ncbi:5855">P. vivax</span>
###xml 303 308 <span type="species:ncbi:9606">human</span>
Plasmodium vivax has been the most common cause of the human malaria parasite in the Brazilian Amazon region over the last seven years [1]. Innate resistance to malaria infections in humans is conferred by different blood group polymorphisms. The association of the Duffy blood group (FY) with P. vivax human malaria has been well-documented, where Duffy-negative individuals are naturally resistant to invasion by this parasite [2].
###end p 11
###begin p 12
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 396 405 396 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fy </italic>
###xml 450 452 450 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 458 459 458 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 505 509 505 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB</italic>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 574 576 574 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 587 589 587 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 677 678 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 685 689 685 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 693 697 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 762 763 762 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 788 790 788 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 812 814 812 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 894 895 894 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 896 897 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1177 1181 1177 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 1189 1190 1189 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1207 1211 1207 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 1239 1241 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1253 1257 1253 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 1503 1507 1503 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 1609 1613 1609 1613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 1634 1636 1634 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1764 1766 1764 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 396 404 <span type="species:ncbi:5855">P. vivax</span>
The Duffy blood group antigen has been identified as a scavenger on the red blood cell (RBC) surface eliminating excesses of circulating toxic chemokines, named Duffy antigen/receptor for chemokines (DARC) [3]. The determinant, a glycoprotein that passes through the membrane seven times, includes a 35-43 KDa epitope in the extracellular, N-terminal domain that mediates erythrocyte invasion by P. vivax merozoites [4]. The Fy gene has two exons (Fya and Fyb) that are encoded by the co-dominant alleles FYA and FYB, located on chromosome 1 [5,6]. The corresponding anti-Fya and anti-Fyb antibodies define four different phenotypes; Fy(a+b+), Fy(a+b-), Fy(a-b+) and Fy(a-b-) [7]. The FYA and FYB alleles differ by a point mutation in the major cDNA transcript [8], encoding glycine in Fya or aspartic acid in Fyb at residue 42 of the most important form of the protein, encoded by the exon 2 [9,8]. The molecular mechanism that gives rise to the null Duffy phenotype [Fy(a-b-)] has been classically associated with a point mutation in the GATA box of the DARC promoter which silences the gene encoding the Duffy system antigens in the RBCs of these individuals resulting in a FYB allele [9]. Recently, the FYA allele has been identified [10] and a new FYB allele was found with three single nucleotide polymorphisms (11). It has been demonstrated in blood donors from Southeast Brazil that Caucasians and African descendents were serologically Fy(b-) with the majority of the African descendents being FYB with the GATA single nucleotide polymorphism (SNP), while the majority of Caucasian typing Fy(b-) had FYB with 265T/298A SNPs [11]. The Fy-negative is common on RBCs of Negro individuals from ethnic African groups, but it is rare in many other populations [12].
###end p 12
###begin p 13
###xml 124 133 124 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 322 331 322 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 694 697 694 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fy </italic>
###xml 736 745 736 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 813 822 813 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 124 132 <span type="species:ncbi:5855">P. vivax</span>
###xml 322 330 <span type="species:ncbi:5855">P. vivax</span>
###xml 339 347 <span type="species:ncbi:9606">patients</span>
###xml 569 577 <span type="species:ncbi:9606">patients</span>
###xml 736 744 <span type="species:ncbi:5855">P. vivax</span>
###xml 813 821 <span type="species:ncbi:5855">P. vivax</span>
###xml 830 838 <span type="species:ncbi:9606">patients</span>
Previous studies have demonstrated that heterozygous Duffy negative malaria individuals remain susceptible to infections by P. vivax [13,14]. It was demonstrated in individuals living in a malaria endemic region of Papua New Guinea that Duffy binding protein adherence to RBCs is significantly reduced for erythrocytes of P. vivax malaria patients who carry one Duffy-negative allele [15]. In addition, it was observed that in different areas from the Brazilian Amazon region some of the Duffy phenotypes showed significant correlation between blood donors and malaria patients [16]. On the other hand, a previous study in the Western Brazilian Amazon region (Rondonia State) did not correlate Fy heterozygosity with protection against P. vivax [17]. The present study reports the Duffy blood group genotyping in P. vivax malaria patients from four different Brazilian endemic areas, exploring these significant phenotypic associations between blood group variants, as well as polymorphic regions of RBC receptors, with susceptibility or resistance to malaria.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study population
###end title 15
###begin p 16
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 807 815 <span type="species:ncbi:9606">patients</span>
###xml 967 979 <span type="species:ncbi:9606">participants</span>
The study took place from May 2003 to August 2005. The vivax malaria patients (n = 312) who were enrolled in this study complied with the following criteria: they sought medical assistance presenting clinical malaria symptoms, were over 18 years old and had positive results for thick blood film/molecular diagnosis. A control group consisted of blood donors (n = 330) and according to the Brazilian blood bank policy they complied with the following criteria: they were over 18 years old, of both genders and belonging to all blood groups. Additionally, their place of birth was in the study area, they reported never suffering from malaria attacks and had no signs of malaria during the initial interview and had negative results for thick blood film/molecular diagnosis. The controls were matched to the patients in respect to age (+/- 5 years), gender and ethnicity. All of the control subjects were genetically independent. Blood samples were collected from all participants (Macapa/Amapa State, Belem/Para State, Porto Velho/Rondonia State and Rio Branco/Acre State), after informed consent.
###end p 16
###begin title 17
Genomic DNA extraction, PCR amplification and RFLP analysis
###end title 17
###begin p 18
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 607 609 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 681 687 671 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 688 690 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 895 898 885 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ban</italic>
###xml 901 904 891 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msp</italic>
###xml 911 914 901 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sty</italic>
###xml 961 963 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
The Duffy blood group genotypes were assessed using PCR/RFLP with modifications as described previously [11]. Briefly, the DNA was extracted from frozen pellets of infected erythrocytes using the Easy-DNAtrade mark extraction kit (Invitrogen, California - USA). The PCR was performed with 100 ng of DNA, 50 pmol of each primer, 2 nmol each dNTP, 1.0 U Taq DNA polymerase, and buffer, in a total volume of 50 muL. The promoter region was amplified using the FYN1 and FYN2 primers that flank the GATA box motif. To determine the Duffy RBC polymorphism, FYAB1 sense, and FYAB2 reverse sense primers were used [18]. The amplification conditions were performed as described by Castilho et al [11]. PCR products were run on 1.5% agarose gel, followed by ethidium bromide staining and photo-documentation using a Gel Doc 1000 (BioRad, Town, USA). The RFPL analysis was digested during three hours with Ban1, MspA1 and Sty1 restriction enzymes as previously described [11].
###end p 18
###begin title 19
Statistical analysis
###end title 19
###begin p 20
###xml 154 162 <span type="species:ncbi:9606">patients</span>
In order to access the significance of the variables and to obtain independence among the proportions, the Fisher's exact test was used. The mean ages of patients and controls were 29 years (+/- 14 SD) and 28 years (+/- 8 SD), respectively. All the studied groups showed no statistically significant differences in mean ages or ethnicity, indicating well-matched populations. The same results were obtained when we compared the two different groups from each area.
###end p 20
###begin title 21
Results
###end title 21
###begin p 22
###xml 116 125 116 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 216 224 216 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB </italic>
###xml 357 361 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 448 459 448 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB-33 </italic>
###xml 463 474 463 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB/FYB-33 </italic>
###xml 543 549 543 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FY</italic>
###xml 549 550 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 549 550 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X</italic></sup>
###xml 552 558 552 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB/FY</italic>
###xml 558 559 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 558 559 558 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X</italic></sup>
###xml 561 567 561 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYX/FY</italic>
###xml 567 569 567 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 567 569 567 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X </italic></sup>
###xml 573 587 573 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33/FYB-33 </italic>
###xml 627 640 627 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33/FYB-33</italic>
###xml 684 693 684 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 116 124 <span type="species:ncbi:5855">P. vivax</span>
###xml 684 692 <span type="species:ncbi:5855">P. vivax</span>
The genotypic and allelic frequencies of the Duffy blood group in the 330 blood donors and 312 patients infected by P. vivax as determined by PCR/RFLP are summarized in Table 1. The data show a high frequency of the FYA/FYB genotype in 199 individuals (31.0%) of the studied population. This is followed by 117 (18.2%) and 94 (14.6%) of homozygotes for the FYB and FYA alleles, respectively. While the frequencies for heterozygote individuals with FYA/FYB-33 and FYB/FYB-33 were comparable at 14.9% (96). Low frequencies were detected for the FYA/FYX, FYB/FYX, FYX/FYX and FYB-33/FYB-33 genotypes. The negative Duffy genotype (FYB-33/FYB-33) was found in both individuals infected by P. vivax and unaffected blood donors.
###end p 22
###begin p 23
###xml 105 116 105 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 105 121 <span type="species:ncbi:5855">Plasmodium vivax</span>
Genotyping results of the Duffy Blood Group System in 642 individuals (donors and patients infected with Plasmodium vivax) from Brazilian Amazon region.
###end p 23
###begin p 24
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY </italic>
###xml 130 139 130 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 203 205 203 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 283 296 283 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33/FYB-3 </italic>
###xml 431 439 431 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB </italic>
###xml 526 535 526 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 591 593 591 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 593 594 593 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 593 594 593 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X</italic></sup>
###xml 594 602 594 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/FYB-33 </italic>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
###xml 130 138 <span type="species:ncbi:5855">P. vivax</span>
###xml 261 269 <span type="species:ncbi:9606">patients</span>
###xml 505 513 <span type="species:ncbi:9606">patients</span>
###xml 526 534 <span type="species:ncbi:5855">P. vivax</span>
Table 2 shows a comparison of the results of genotyping and inferred phenotypes of FY among blood donors and patients infected by P. vivax in the Amazon region. In respect to the allelic combinations of FY, there was a significant difference between donors and patients only for the FYB-33/FYB-3 genotype (P = 0.0003). As for the heterozygotes, the results demonstrated a significant difference (P = 0.0404) between those with the FYA/FYB genotype, which was lower for blood donors (90 - 27.27%) than for patients infected by P. vivax (109 - 34.93%). No individuals were identified with the FYX/FYB-33 genotype.
###end p 24
###begin p 25
###xml 134 143 134 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
###xml 134 142 <span type="species:ncbi:5855">P. vivax</span>
Comparison of genotyping results and allele frequencies of the Duffy Blood Group System among blood donors and patients infected with P. vivax from Brazilian Amazon region.
###end p 25
###begin p 26
* Fisher's Exact Test.
###end p 26
###begin p 27
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33 </italic>
###xml 191 195 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 376 378 376 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 378 380 378 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 378 380 378 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X </italic></sup>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
###xml 263 271 <span type="species:ncbi:9606">patients</span>
The frequency of individuals with the FYB-33 allele among blood donors was 35.15% versus 24.36% in patients. This difference was statistically significant (P = 0.0033). The prevalence of the FYB allele was significantly higher (P = 0.0358) among malaria-infected patients. However, significant differences were not detected in respect to the frequency of individuals with the FYX and FYA alleles in the two study groups (Table 2).
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 171 180 171 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 462 471 462 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 53 59 <span type="species:ncbi:9606">humans</span>
###xml 171 179 <span type="species:ncbi:5855">P. vivax</span>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 462 470 <span type="species:ncbi:5855">P. vivax</span>
Thus far, innate resistance to malaria infections in humans has been attributed to blood group polymorphisms. Duffy blood group polymorphisms are important in areas where P. vivax predominates, because this molecule acts as a receptor for this protozoan (but not for the other human malaria parasites) on the surface of RBCs [19]. Field observations from West Africa and Ethiopia have indeed established a strong correlation between absence or low endemicity of P. vivax malaria and the high prevalence of the Duffy negative allele [20,21]. Little is known on the frequency of RBC polymorphisms that confer either partial or complete resistance against malaria. The data obtained in the present study emphasize the importance of the evaluation of Duffy blood group genotypes in malaria endemic areas of the Brazilian Amazon region.
###end p 29
###begin p 30
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 611 614 611 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY </italic>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 767 770 767 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA</italic>
###xml 772 776 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 780 787 780 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33 </italic>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1069 1071 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1108 1110 1108 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1123 1125 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1147 1149 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 674 682 <span type="species:ncbi:9606">patients</span>
###xml 697 702 <span type="species:ncbi:9606">human</span>
The Brazilian population has a highly heterogeneous ethnic composition, a result of the hybridization of the numerous native indigenous populations and immigrants from Europe, Africa and Asia. The immigration flow was not uniform in the different regions of the country [22-24]. The differential distribution of Duffy antigenic determinants among ethnic groups is an aspect characteristic of this blood system. Hence, this has been used as a marker for the ethnic composition as well as an indicator in the populational evolution. In the current study, significant differences in the allelic frequencies of the FY gene were identified when compared with previous studies of patients infected with human plasmodium in Brazilian Amazon regions [17,25-27]. However, the FYA, FYB and FYB-33 alleles showed differential distributions compared to the population of the southeastern region of Brazil [11]. The genotypic compositions obtained in this study demonstrated significant variations compared to previous studies performed in the states of Para and Rio Grande do Sul [28,29] and in the cities of Sao Paulo [30], Campinas [11] and Ribeirao Preto [31] all of which are in the state of Sao Paulo, Southeastern region of Brazil.
###end p 30
###begin p 31
###xml 47 55 47 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB </italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 166 177 166 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB-33 </italic>
###xml 181 192 181 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB/FYB-33 </italic>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 207 221 207 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33/FYB-33 </italic>
###xml 286 295 286 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 472 481 472 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 698 706 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB </italic>
###xml 710 721 710 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB/FYB-33 </italic>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 848 862 848 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33/FYB-33 </italic>
###xml 969 971 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 286 294 <span type="species:ncbi:5855">P. vivax</span>
###xml 449 457 <span type="species:ncbi:9606">patients</span>
###xml 472 480 <span type="species:ncbi:5855">P. vivax</span>
The currently obtained results showed that the FYA/FYB genotype was the most common, followed by the homozygotes for the FYB and FYA alleles and by the heterozygotes FYA/FYB-33 and FYB/FYB-33 (Table 1). The FYB-33/FYB-33 genotype, which is classically seen in individuals unaffected by P. vivax infection, was identified in 3.2% of the general population and in 5.5% of blood donors. These numbers differ from previous reports on a group of malaria patients uninfected by P. vivax in the state of Rondonia [17], where the frequency of this genotype was 12% and also for a mixed sample from the Northern and Southeastern regions of Brazil [27]. Some populations had higher genotypic frequencies for FYA/FYB and FYB/FYB-33 than for a caucasian-like and negroid population from the Southeastern of Brazil [11]. On the other hand, the frequency of the FYB-33/FYB-33 genotype was lower. In fact, with the exception of negroid ethnic groups, this genotype is extremely rare [12,30,32,33].
###end p 31
###begin p 32
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 243 247 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 690 694 690 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 767 774 767 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33 </italic>
###xml 968 970 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1052 1054 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1055 1057 1055 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1078 1080 1078 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 1080 1082 1080 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 1080 1082 1080 1082 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X </italic></sup>
###xml 1260 1262 1260 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1284 1286 1284 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 50 57 <span type="species:ncbi:9606">peoples</span>
The FYA allele is common in European and Oriental peoples but it is rare in African Negroes. Additionally, the FYB is more common in populations classified as white than in asiatic and negroid populations [34,35]. The frequency of the FYA and FYB alleles in the Brazilian Amazon population was higher than those in the Southeastern region [11] probably due to the massive influence of Portuguese colonization in the North region of Brazil as well as the presence of Amerindians [36], as recent molecular analysis has corroborated that Amerindians have an Asian origin [37]. Indeed, in the North region of Brazil, studies carried out with different tribes of Amerindians have shown that the FYA allele is the most common [31,38]. As expected, a lower frequency of the FYB-33 allele was observed in the North region (P = 0.0001). Although a high prevalence of this allele was demonstrated in isolated communities in the states of Amapa and Para, North region of Brazil [39], the introduction of a negroid ethnic component in the Amazon region is recent [40,41]. In respect to the FYX allele, there does not seem to be a differential ethnic distribution as, the frequency detected here is similar to those described in other Caucasian-like populations in Brazil [11] and also in Europe [42].
###end p 32
###begin p 33
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY </italic>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
The different FY allelic frequencies in individuals from North compared to Southeastern Brazil, may be due to the contribution of the three major ethnic groups (Europeans, in particular Portuguese; Blacks and Amerindians) in the formation of both populations. The Amerindian contribution was higher in the north of the country whereas European migration took place more in the South and Southeastern regions [43-45]. In spite of the current knowledge of the relationship between structure/function and tissue location of DARC, the functional significance of each of the alleles and the different genotypic combinations require further elucidation. The variation in the ethnic composition of the urban and rural populations of the Brazilian Amazon region and of distinct regions in Brazil [26,46], may influence the allelic and genotypic distributions reflecting in matrixes of genetic mechanisms favorable to the susceptibility to infectious and parasitic diseases, in particular to malaria.
###end p 33
###begin p 34
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY </italic>
###xml 55 61 55 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33</italic>
###xml 222 229 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33 </italic>
###xml 316 330 316 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 365 374 365 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 412 419 412 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33 </italic>
###xml 446 450 446 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 575 576 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 602 606 600 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 630 633 628 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA</italic>
###xml 633 638 631 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">null </italic>
###xml 633 638 631 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>null </italic></sup>
###xml 646 648 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 671 678 669 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33 </italic>
###xml 772 774 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 775 777 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 857 859 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 860 862 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 965 974 963 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 1029 1031 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1032 1034 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1046 1056 1044 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY/FYB-33 </italic>
###xml 1175 1184 1173 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 1193 1195 1191 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1437 1446 1435 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 1511 1514 1509 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA</italic>
###xml 1514 1519 1512 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">null </italic>
###xml 1514 1519 1512 1517 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>null </italic></sup>
###xml 1527 1529 1525 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
###xml 316 329 <span type="species:ncbi:5833">P. falciparum</span>
###xml 365 373 <span type="species:ncbi:5855">P. vivax</span>
###xml 965 973 <span type="species:ncbi:5855">P. vivax</span>
###xml 1437 1445 <span type="species:ncbi:5855">P. vivax</span>
The frequency of the allele with the FY GATA mutation (FYB-33) was greater in blood donors than in patients infected with malaria (P = 0.0033), suggesting that there is a reduction in the infection rate of carriers of the FYB-33 allele. These results were recently reinforced by data from of individuals infected by P. falciparum when compared to those infected by P. vivax in Brazilian Amazon regions [27]. The FYB-33 allele is a variant of the FYB allele resulting from a T --> C point mutation in the gene promoter region (neucleotide-33), which abolishes its expression [9]. The same occurs in the FYA allele, determining the FYAnull allele [10]. The presence of the FYB-33 allele results in a 50% reduction in the Duffy protein expression on the erythrocyte surface [15,47]. This process demonstrates the action of the dose-related effect of the gene [15,48], which may limit the invasion process of red blood cells by the parasite, although susceptibility to P. vivax may occur in heterozygotic Duffy-negative individuals [13,14]. Thus the FY/FYB-33 genotypic combination, with either Fy(a+b-) or Fy(b+b-), seems to convey a reduction in the susceptibility to malaria. In vitro studies [15] support this hypothesis as RBCs that express these phenotypes have a significant reduction in cytoadherence of the parasite when compared to RBCs that express Fy(b+b+). Recently, in Papua New Guinea, a significant reduction in infection by P. vivax was observed in Duffy negative individuals heterozygotic for the FYAnull allele [49].
###end p 34
###begin p 35
###xml 62 75 62 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33/FYB-33</italic>
###xml 347 356 347 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 705 714 705 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 822 826 822 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 1055 1061 1055 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33</italic>
###xml 1181 1190 1181 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 1225 1232 1225 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33 </italic>
###xml 1506 1515 1506 1515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 347 355 <span type="species:ncbi:5855">P. vivax</span>
###xml 621 629 <span type="species:ncbi:9606">patients</span>
###xml 705 713 <span type="species:ncbi:5855">P. vivax</span>
###xml 1181 1189 <span type="species:ncbi:5855">P. vivax</span>
###xml 1506 1514 <span type="species:ncbi:5855">P. vivax</span>
In this study a low frequency of the negative Duffy genotype (FYB-33/FYB-33) was detected among uninfected subjects. As has previously been demonstrated, the absence of the Fy antigen in many ethnic Negro groups and their descendents, does not seem to exert any deleterious effect, however it does bestow a natural resistance against infection by P. vivax [2,9,14,35,50,51]. These individuals are homozygotes for the FYB mutation in the GATA, that completely abolishes the Fy expression in erythrocytes but not in cells of other tissues [9]. Recent reports have provided evidence on the transmission among Duffy-negative patients in Africa [52] and in Brazil [53]. These data suggest the possibility that P. vivax is utilizing alternative receptors, apart from Fy, for binding in the erythrocyte invasion process. Whether FYB carrying the GATA box mutation is the primordial gene that encodes the Duffy system antigens or whether the GATA box mutation has evolved to escape malaria infection per se is controversial. However, the presence of this allele (FYB-33) may be a demonstration of the selection advantage by mutation in the population. Thus, in the Brazilian Amazon, where P. vivax predominates, the frequency of the FYB-33 allele is higher than expected given the ethnic population, both in terms of heterozygotes and homozygotes. This might, over time, cause an increase in the number of Duffy-negative individuals in the population and, as a consequence, a reduction in the rate of infection by P. vivax in this region.
###end p 35
###begin p 36
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax</italic>
###xml 83 85 83 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 85 87 85 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 85 87 85 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X </italic></sup>
###xml 123 129 123 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FY</italic>
###xml 129 131 129 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X </italic></sup>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB/FY</italic>
###xml 162 164 162 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 162 164 162 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X </italic></sup>
###xml 179 181 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 181 182 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X</italic></sup>
###xml 182 185 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/FY</italic>
###xml 185 187 185 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 185 187 185 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X </italic></sup>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 445 447 445 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 447 448 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 447 448 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X</italic></sup>
###xml 648 652 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 802 804 802 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 804 806 804 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 804 806 804 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X </italic></sup>
###xml 807 809 807 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 809 811 809 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WK</italic>
###xml 809 811 809 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WK</italic></sup>
###xml 957 959 957 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 959 961 959 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 959 961 959 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>X </italic></sup>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 37 45 <span type="species:ncbi:5855">P. vivax</span>
###xml 233 241 <span type="species:ncbi:9606">patients</span>
In the group of patients infected by P. vivax, different allelic combinations with FYX were detected, including five (1.6%)FYA/FYX individuals, four (1.3%) FYB/FYX and two (0.6%) FYX/FYX (Table 2). The frequency of this allele among patients and blood donors did not show statistical differences (P = 0.3873). Studies carried out in blood samples from European and American Caucasians and Afro-American individuals, demonstrated that the C265T (FYX) mutation altered the Duffy protein expression on the RBC surface differently, depending on the ethnic group, using at least two mechanisms. One mechanism involves silent transcription in one of the FYB alleles and the other affects the translation and/or the stability of the protein [47,54]. These studies showed that heterozygote individuals for the FYX (FYWK) allele have 50% less of the Duffy protein on the surface of the membrane of the erythrocyte. On the other hand, individuals homozygotic for the FYX allele have about one tenth of the antigen expression in the erythrocytes [47]. However, the information shown by the present study suggest that these polymorphisms do not seem to be associated with susceptibility to malaria.
###end p 36
###begin p 37
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB </italic>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 284 292 284 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax</italic>
###xml 450 461 450 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 988 997 988 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 1131 1140 1131 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1349 1351 1349 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1399 1403 1399 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 1407 1411 1407 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
###xml 284 292 <span type="species:ncbi:5855">P. vivax</span>
###xml 632 640 <span type="species:ncbi:9606">patients</span>
###xml 988 996 <span type="species:ncbi:5855">P. vivax</span>
###xml 1641 1646 <span type="species:ncbi:9606">human</span>
As illustrated in Table 2, a higher frequency of the FYA/FYB genotype in patients compared to blood donors (P = 0.0404) was detected. In principle, this seems to indicate that the condition of heterozygosis, resulting from the expression of the FYA and FYB genes, favors infection by P. vivax. In fact, as has already been demonstrated by us, based on a phenotyping study, Fy(a+b+) individuals may be more susceptible to infection by this species of Plasmodium [16]. Although no qualitative or quantitative measurements of the Duffy glycoprotein expressions were made in this study, we saw a larger number of malaria episodes among patients with the heterozygote genotype than the homozygote genotype. The basis of this observation has not been determined yet, but the phenotypic [16] and genotypic data presented from the same Brazilian Amazon areas associated with pertinent publications, point to the possibility that heterozygote individuals modulate the susceptibility to malaria by P. vivax by means of quantitative and/or qualitative variations that affect the Duffy antigen expression on erythrocytes. In the first aspect, in vitro studies demonstrate differences in the levels of the expression of FY glycoprotein on the surface of the reticulocytes of Caucasian-like and Afro-American individuals with the Fy(a+b+) erythrocytic phenotype [48]. These authors verified that individuals with FYA and FYB alleles expressed a lower quantity of DARC than heterozygotes. Hence, it is possible that heterozygote individuals have a greater repertory of receptors for the possible variations that occur in the parasite protein binder to the human erythrocytes.
###end p 37
###begin p 38
###xml 86 95 86 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 260 282 260 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 612 618 612 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vivax </italic>
###xml 675 679 675 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA </italic>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB </italic>
###xml 713 721 713 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax</italic>
###xml 991 999 991 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax</italic>
###xml 1171 1173 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1174 1176 1174 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 86 94 <span type="species:ncbi:5855">P. vivax</span>
###xml 189 194 <span type="species:ncbi:9606">human</span>
###xml 260 281 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 713 721 <span type="species:ncbi:5855">P. vivax</span>
###xml 991 999 <span type="species:ncbi:5855">P. vivax</span>
The recent demonstration of polymorphisms in the Duffy binding protein in isolates of P. vivax from the Brazilian Amazon [55] seems to support the observed results. An association, between human receptor polymorphisms and variations in the parasite binders of Plasmodium falciparum that modulate susceptibility to malaria, was also demonstrated [19,56-60]. Hence, apart from the different levels of the expression, the specific conformation of the Fya and Fyb antigens may determine differences in the susceptibility to infection. Nevertheless, one of the possible consequences of differential susceptibility to vivax malaria could be modifications in allelic frequencies of FYA and FYB in populations exposed to P. vivax, the most prevalent species in the Brazilian Amazon region. If in fact this process occurs as a consequence of infection, it seems to be necessary, but not sufficient to eliminate heterozygote individuals, even if they are affected by repetitive episodes of malaria by P. vivax, as the infection is rarely severe and occurs in the entire age range with different frequencies for different ages and regions of the Brazilian Amazon without lethality [61,62].
###end p 38
###begin p 39
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 500 514 500 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 814 823 814 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 831 839 831 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB/FYB </italic>
###xml 889 895 889 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1107 1120 1107 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 179 187 <span type="species:ncbi:9606">patients</span>
###xml 500 513 <span type="species:ncbi:5833">P. falciparum</span>
###xml 814 822 <span type="species:ncbi:5855">P. vivax</span>
###xml 1086 1094 <span type="species:ncbi:9606">patients</span>
###xml 1107 1120 <span type="species:ncbi:5833">P. falciparum</span>
Based on the significant associations described herein, our data differ from previous studies [17] carried out in the western Brazilian Amazon region as well as recent studies of patients from the Brazilian Amazon as a whole [27]. In respect to the first studies, these differences may be a result of the small sample sizes initially evaluated; the control group of the current study was composed of blood donors who reported never having experienced malaria against samples from individuals who had P. falciparum previously evaluated and the various ethnic groups in the different regions studied today (Eastern and Western Amazon). In relation to the recent studies, different to the findings observed in this study Brazilian Amazon population, the authors detected a significant association among infections by P. vivax and the FYB/FYB genotype, also conflicting with results of Wooley et al [48] in North American individuals (Caucasians and Afro-Americans). These divergences probably occurred due to the smaller sample size involved, and the fact that the control group consisted patients infected by P. falciparum.
###end p 39
###begin title 40
Conclusion
###end title 40
###begin p 41
###xml 135 137 135 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY</italic>
###xml 564 572 564 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB </italic>
###xml 640 646 640 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33</italic>
###xml 735 744 735 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 873 880 873 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYB-33 </italic>
###xml 895 903 895 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYA/FYB </italic>
###xml 1123 1132 1123 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 735 743 <span type="species:ncbi:5855">P. vivax</span>
###xml 1123 1131 <span type="species:ncbi:5855">P. vivax</span>
The Brazilian population presents an elevated degree of miscegenation which is implicated in variations in the allelic distribution of FY, which was also found in this study. Future analyses that consider haplotypic frequencies of the alleles and quantification of the DARC expression in populational groups in endemic and non-endemic areas, increasing the knowledge on the dynamics of this gene and its possible contribution as a modulator in the susceptibility to malaria. The data obtained in the present study supports the hypothesis that individuals with the FYA/FYB genotype have higher susceptibility to malaria. The presence of the FYB-33allele may be a selective advantage in the population, reducing the rate of infection by P. vivax in this region. However, the populational and longitudinal studies must be amplified accompanying groups of individuals with the FYB-33 allele and the FYA/FYB genotype, including clinical parameters, as well as the evaluation of their expressions which may contribute to better elucidate the physiopathologic differences in this parasite/host relationship in regions endemic for P. vivax malaria, in particular the Brazilian Amazon.
###end p 41
###begin title 42
Authors' contributions
###end title 42
###begin p 43
###xml 78 87 78 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 78 86 <span type="species:ncbi:5855">P. vivax</span>
CEC carried out all genotype assay. AADC, VSDC and CEC collected samples from P. vivax malaria individuals and blood donors. CEC, LCM, CRBD and LC participated in the design of the study and drafted the manuscript. RLM and ARBR conceived of the study and participated in all aspects of its design, acquisition of funding, execution, coordination and manuscript preparation. All authors read and approved the final manuscript.
###end p 43
###begin title 44
Acknowledgements
###end title 44
###begin p 45
To all individuals enrolled in this study and to Blood Bank Managing Director of the studied areas for help in blood donor samples collection. We thank Aline Barroso, Maria Cristina Figueredo and Mauro Tada for help in malaria field work. To Professor Luiz Hildebrando Pereira da Silva for facilities at CEPEM. Financial support was provided by FAPESP (Process 02/9546-1), CNPq (Process 302353/2003-8). C.E.C. is a PhD student from Faculdade de Medicina de Sao Jose do Rio Preto. The protocol for this study was reviewed and approved by the Research Board of the Faculdade de Medicina de Sao Jose do Rio Preto.
###end p 45
###begin article-title 46
Clinical and molecular aspects of severe malaria
###end article-title 46
###begin article-title 47
###xml 25 42 25 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FYFY</italic>
###xml 25 41 <span type="species:ncbi:5855">Plasmodium vivax</span>
The resistance factor to Plasmodium vivax in Blacks: Duffy blood group genotype FYFY
###end article-title 47
###begin article-title 48
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin
###end article-title 48
###begin article-title 49
###xml 115 132 115 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 115 131 <span type="species:ncbi:5855">Plasmodium vivax</span>
Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy group system and the receptor for the Plasmodium vivax malaria parasite
###end article-title 49
###begin article-title 50
###xml 70 73 <span type="species:ncbi:9606">man</span>
Probable assignment of the Duffy blood group locus to chromosome 1 in man
###end article-title 50
###begin article-title 51
Integration of gene maps: chromosome 1
###end article-title 51
###begin article-title 52
A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associate with na altered erythrocyte phenotype
###end article-title 52
###begin article-title 53
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 94 96 94 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 207 208 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
Mutation in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype
###end article-title 53
###begin article-title 54
Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individual
###end article-title 54
###begin article-title 55
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY*A</italic>
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">null </italic>
###xml 17 22 17 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>null </italic></sup>
###xml 27 43 27 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax</italic>
###xml 27 43 <span type="species:ncbi:5855">Plasmodium vivax</span>
Emergence of FY*Anull in a Plasmodium vivax-endemic region of Papua New Guinea
###end article-title 55
###begin article-title 56
A novel Fy allele in Brazilians
###end article-title 56
###begin article-title 57
###xml 27 46 27 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium knowlesi</italic>
###xml 27 46 <span type="species:ncbi:5850">Plasmodium knowlesi</span>
Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants
###end article-title 57
###begin article-title 58
Erythrocyte receptor for malaria merozoites
###end article-title 58
###begin article-title 59
###xml 89 98 89 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. vivax </italic>
###xml 89 97 <span type="species:ncbi:5855">P. vivax</span>
Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood-stage infection
###end article-title 59
###begin article-title 60
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Frequencies of ABO, MNSs and Duffy phenotypes among blood donors and malaria patients from four Brazilian Amazon areas
###end article-title 60
###begin article-title 61
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Duffy blood group genotypes among malaria patients in Rondonia, Western Brazilian Amazon
###end article-title 61
###begin article-title 62
DNA from urine sediment or buccal cells can be used for blood group molecular genotyping
###end article-title 62
###begin article-title 63
Impact of malaria on genetic polymophism and genetic diseases in Afrincans and African Americans
###end article-title 63
###begin article-title 64
The Duffy blood group and malaria prevalence in Gambian West Africans
###end article-title 64
###begin article-title 65
Duffy Blood Types and vivax Malaria in Ethiopia
###end article-title 65
###begin article-title 66
Genetic and anthropological studies in the island of Itaparica, Bahia, Brazil
###end article-title 66
###begin article-title 67
Blood polymorphisms and racial admixture in two Brazilian populations
###end article-title 67
###begin article-title 68
Hereditary hemoglobin disorders in a Brazilian population
###end article-title 68
###begin article-title 69
A Rural Community in a Brazilian Western Amazonian Region: Some Demographic and Epidemiological Patterns
###end article-title 69
###begin article-title 70
Ethnic Admixture Composition of Two Western Amazonian Populations
###end article-title 70
###begin article-title 71
###xml 104 130 104 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax invasion </italic>
###xml 104 120 <span type="species:ncbi:5855">Plasmodium vivax</span>
Real-time multiplex allele-specific polymerqase chain reaction for genotyping of the Duffy antigen, the Plasmodium vivax invasion receptor
###end article-title 71
###begin article-title 72
Genetic studies in three South American black populations
###end article-title 72
###begin article-title 73
Genetics, Surnames, Grandparents'Nationalities, and Ethnic Admixture in Southern Brazil - Do the Patterns of Variation Coincide?
###end article-title 73
###begin article-title 74
Estudo de grupos sanguineos em doadores de sangue caucasoides e negroides na cidade de Sao Paulo
###end article-title 74
###begin article-title 75
###xml 61 67 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Duffy </italic>
The mutation G298A-->Ala100Thr on the coding sequence of the Duffy antigen/chemokine receptor gene in non-caucasian Brazilians
###end article-title 75
###begin article-title 76
###xml 40 57 40 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 40 56 <span type="species:ncbi:5855">Plasmodium vivax</span>
The Duffy blood group and resistance to Plasmodium vivax in Honduras
###end article-title 76
###begin article-title 77
Duffy phenotypes in Malaysian populations: correction of previous unusual findings
###end article-title 77
###begin article-title 78
The Duffy protein: A malarial and chemokine receptor
###end article-title 78
###begin article-title 79
###xml 40 43 <span type="species:ncbi:9606">Men</span>
###xml 48 53 <span type="species:ncbi:9606">Women</span>
Differential Contribution of Indigenous Men and Women to the Formation of an Urban Population in the Amazon Region as Revealed by mtDNA and Y-DNA
###end article-title 79
###begin article-title 80
The central Siberian origin for native American Y chromosomes
###end article-title 80
###begin article-title 81
Duffy blood group gentypes among African-Brazilian communities of the Amazon region
###end article-title 81
###begin article-title 82
The Ancestry of Brazilian mtDNA Lineages
###end article-title 82
###begin article-title 83
Historical Genetics: Spatiotemporal Analysis of the Formation of the Brazilian Population
###end article-title 83
###begin article-title 84
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY*X </italic>
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY </italic>
FY*X real-time polymerase chain reaction with melting curve analysis associated with a complete one-step real-time FY genotyping
###end article-title 84
###begin article-title 85
The indigenous contribution to the formation of the population of the Brazilian Amazon region
###end article-title 85
###begin article-title 86
Migration and ethnic change in an admixed population from the Amazon region (Santarem, Para)
###end article-title 86
###begin article-title 87
The phylogeography of Brazilian Y-chromosome lineages
###end article-title 87
###begin article-title 88
The Amazonian microcosm
###end article-title 88
###begin article-title 89
Molecular mechanisms that lead to reduced expression of Duffy antigens
###end article-title 89
###begin article-title 90
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FY </italic>
Differential expression of the Duffy antigen receptor for chemokines according to RBC age and FY genotype
###end article-title 90
###begin article-title 91
###xml 8 25 8 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 8 24 <span type="species:ncbi:5855">Plasmodium vivax</span>
Reduced Plasmodium vivax Erythrocyte Infection in PNG Duffy-Negative Heterozygote
###end article-title 91
###begin article-title 92
###xml 64 69 <span type="species:ncbi:9606">human</span>
The Duffy blood groups, vivax malaria, and malaria selection in human populations: a review
###end article-title 92
###begin article-title 93
From malaria to chemokine receptor: The emerging physiologic role of the Duffy blood group antigen
###end article-title 93
###begin article-title 94
###xml 29 46 29 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 29 45 <span type="species:ncbi:5855">Plasmodium vivax</span>
Evidence for transmission of Plasmodium vivax among a Duffy antigen negative population in western Kenya
###end article-title 94
###begin article-title 95
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 0 16 <span type="species:ncbi:5855">Plasmodium vivax</span>
Plasmodium vivax infection among Duffy antigen-negative individuals from de Brazilian Amazon region: an exception?
###end article-title 95
###begin article-title 96
Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy* individuals
###end article-title 96
###begin article-title 97
###xml 84 101 84 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 84 100 <span type="species:ncbi:5855">Plasmodium vivax</span>
The pattern of major polymorphisms in the Duffy binding protein ligand domain among Plasmodium vivax isolates from the Brazilian Amazon area
###end article-title 97
###begin article-title 98
The Role of Red Blood Cell Polymorphisms in Resistance and Susceptibility to Malaria
###end article-title 98
###begin article-title 99
Blood Group Associations With Parasites, Bacteria, and Viruses
###end article-title 99
###begin article-title 100
Evolutionary and Historical Aspects of the Burden of Malaria
###end article-title 100
###begin article-title 101
Erythrocyte polymorphisms and malaria parasite invasion in Papua New Guinea
###end article-title 101
###begin article-title 102
###xml 52 73 52 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 52 73 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Enhanced invasion of blood group A1 erythrocytes by Plasmodium falciparum
###end article-title 102
###begin article-title 103
###xml 32 49 32 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium vivax </italic>
###xml 53 75 53 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 32 48 <span type="species:ncbi:5855">Plasmodium vivax</span>
###xml 53 74 <span type="species:ncbi:5833">Plasmodium falciparum</span>
High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian population
###end article-title 103
###begin article-title 104
The Association of Genetic Markers and Malaria Infection in the Brazilian Western Amazonian Region
###end article-title 104

